Cover Image
Market Research Report

Global Clinical Nutrition Market Forecast 2019-2028

Published by Inkwood Research Product code 952510
Published Content info 174 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Clinical Nutrition Market Forecast 2019-2028
Published: August 3, 2020 Content info: 174 Pages
Description

KEY FINDINGS

The global clinical nutrition market is projected to register a CAGR of 5.11% during the forecast period, 2019-2028. The factors contributing to the growth of the market are the growing prevalence of lifestyle-associated diseases, increasing geriatric population, rising demand in developing countries, and a high occurrence of malnutrition among patients.

MARKET INSIGHTS

Clinical nutrition is a pharmaceutical product that keeps a patient healthy. It enhances the metabolic system through sufficient provision of supplements like vitamins and minerals. It also treats diseases that impact the intestinal absorption, metabolism of constituents of diet, and prevent diet-related diseases. There is a rise in the need for clinical nutrition due to growing chronic and lifestyle-diseases like diabetes mellitus and inflammatory bowel disease. The total burden of cancer across the world is evaluated to have risen to 18.1 million new cases. Many more diseases like cachexia, anorexia, food allergy, etc. require clinical nutrition. The patients often have nutritional deficiency problems. In the US, every year, almost 150,000 infants and hospitalized patients get nutrition support. Therefore, the increasing number of nutrition-related diseases across the globe is projected to drive the demand for clinical nutrition.

However, the lack of awareness regarding clinical nutrition and its availability in both, developing and developed countries, is hindering the growth of the market.

REGIONAL INSIGHTS

The global clinical nutrition market is geographically segmented into Asia Pacific, North America, Europe, and the rest of the world, for further evaluation. North America procured the largest revenue share in 2019, given the relentless R&D toward the development of innovative clinical nutrition, along with the increasing aging population and chronic diseases.

COMPETITIVE INSIGHTS

With a significant number of vendors, the market is assessed to be highly competitive. Some of the established companies in the market include, American Regent Inc, B. Braun, Baxter International Inc, BASF SE, Abbott Laboratories, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32942

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
    • 3.2.2. RISE IN ELDERLY POPULATION
    • 3.2.3. HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
    • 3.2.4. SURGING DEMAND IN DEVELOPING ECONOMIES
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF AWARENESS FOR CLINICAL NUTRITION
    • 3.3.2. COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
    • 3.3.3. STRINGENT REGULATIONS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY ROUTE OF ADMINISTRATION

  • 5.1. ORAL
  • 5.2. ENTERAL
  • 5.3. PARENTERAL

6. MARKET BY APPLICATION

  • 6.1. CANCER
  • 6.2. NEUROLOGICAL DISEASES
  • 6.3. GASTROINTESTINAL DISORDERS
  • 6.4. METABOLIC DISORDERS
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. PEDIATRIC
  • 7.2. GERIATRIC
  • 7.3. ADULTS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. GERMANY
    • 8.2.2. FRANCE
    • 8.2.3. THE UNITED KINGDOM
    • 8.2.4. ITALY
    • 8.2.5. RUSSIA
    • 8.2.6. BELGIUM
    • 8.2.7. POLAND
    • 8.2.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. JAPAN
    • 8.3.2. CHINA
    • 8.3.3. INDIA
    • 8.3.4. AUSTRALIA & NEW ZEALAND
    • 8.3.5. SOUTH KOREA
    • 8.3.6. THAILAND
    • 8.3.7. INDONESIA
    • 8.3.8. VIETNAM
    • 8.3.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPANY PROFILES

  • 9.1. ABBOTT LABORATORIES
  • 9.2. AMERICAN REGENT INC
  • 9.3. BASF SE
  • 9.4. BAXTER INTERNATIONAL INC
  • 9.5. B. BRAUN
  • 9.6. DANONE
  • 9.7. EXELA PHARMA SCIENCES
  • 9.8. GRIFOLS SA
  • 9.9. LONZA LTD
  • 9.10. MEIJI HOLDINGS CO LTD
  • 9.11. NESTLE HEALTH SCIENCE
  • 9.12. OTSUKA HOLDINGS CO LTD
  • 9.13. RECKITT BENCKISER GROUP PLC
  • 9.14. SANOFI
  • 9.15. SICHUAN KELUN PHARMACEUTICAL CO LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL NUTRITION
  • TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2019 AND 2050
  • TABLE 3: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 4: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL ORAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 6: GLOBAL ORAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL ENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 8: GLOBAL ENTERAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL PARENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 10: GLOBAL PARENTERAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL CANCER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 14: GLOBAL CANCER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL NEUROLOGICAL DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: GLOBAL NEUROLOGICAL DISEASES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL GASTROINTESTINAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL GASTROINTESTINAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 22: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 24: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 25: GLOBAL PEDIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 26: GLOBAL PEDIATRIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 27: GLOBAL GERIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 28: GLOBAL GERIATRIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL ADULTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: GLOBAL ADULTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL CLINICAL NUTRITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 32: GLOBAL CLINICAL NUTRITION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 33: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 34: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 35: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 37: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 39: REST OF WORLD CLINICAL NUTRITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: REST OF WORLD CLINICAL NUTRITION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: MAJOR CATEGORIES OF GLOBAL HEALTH SPENDING, 2017
  • FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING
  • FIGURE 3: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: KEY INVESTMENT INSIGHTS
  • FIGURE 7: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 8: GLOBAL CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019
  • FIGURE 12: GLOBAL CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 16: TOP 10 COUNTRIES OR TERRITORIES FOR NUMBER OF PEOPLE WITH DIABETES (20-79*YEARS) IN 2019 (MILLION)
  • FIGURE 17: GLOBAL CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, IN 2019
  • FIGURE 19: GLOBAL CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 23: THE UNITED STATES CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 24: CANADA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 25: EUROPE CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 26: GERMANY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 27: FRANCE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 28: THE UNITED KINGDOM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 29: ITALY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: RUSSIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: BELGIUM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 32: POLAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: REST OF EUROPE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: ASIA PACIFIC CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 35: JAPAN CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: CHINA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: INDIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: AUSTRALIA & NEW ZEALAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: SOUTH KOREA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: THAILAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 41: INDONESIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: VIETNAM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: REST OF WORLD CLINICAL NUTRITION MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 45: LATIN AMERICA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
Back to Top